Abstract

Adverse effects can occur owing to anorexia, which can reduce treatment compliance and worsen the patients overall condition. One such side effect, namely drug-induced taste and smell disorders, reduces patients quality of life. Although antibiotics can cause taste and smell disorders, a few studies have examined antibiotic-induced taste and smell disorders. Therefore, this study comprehensively analyzed the relationship between taste and smell disorders and antibiotic usage. The side effects of antibiotics were investigated using the FDA Adverse Event Reporting System database (FAERS). The reporting odds ratios between the listed drugs and taste and smell disorders P values were comprehensively calculated. Adjusted odds ratios were calculated to account for patient background. Furthermore, to clarify the feature of this adverse effect, shape parameters indicating the expression pattern were calculated. Signals that induced taste and smell disorders were detected for six antibiotics, including drugs for which this event is not described in the package insert in Japan. Multiple logistic regression analysis suggested an association of taste and smell disorders with gender, hypertension, mental disorder, and cancer. The median time to onset of antibiotic-induced taste and smell disorders was 2–5 days. Six antibiotics could be analyzed, and four of these drugs matched those with detected signals. Our study supported previous findings on gender and age. Furthermore, antibiotic-induced taste and smell disorders are likely to develop in the early stage of treatment. For these reasons, it is important to remember the risk of developing of taste and smell disorders when administering antibiotics. In addition, it is recommended that the patient be monitored carefully for at least 1 week before initiating treatment, and the patients course should be followed for at least 2 months.

Highlights

  • Adverse effects can occur owing to anorexia, which can reduce treatment compliance and worsen the patients overall condition

  • Since it was confirmed that similar results could be obtained when the total number of reports was added up, the maximum reported component of each antibiotic was used as the representative value in this study

  • The possibility of a false signal was considered regarding clindamycin. For some of these drugs, taste and smell disorders is not listed as an adverse event (AE) in the package insert in Japan

Read more

Summary

Introduction

Adverse effects can occur owing to anorexia, which can reduce treatment compliance and worsen the patients overall condition One such side effect, namely drug-induced taste and smell disorders, reduces patients quality of life. By clarifying the relationship between taste and smell disorders and each antibiotic, we aim to obtain information that contributes to reducing AEs. We used the FDA Adverse Event Reporting System (FAERS) to assess AEs based on the reporting odds ratio (ROR)[9,10,11,12,13]. Using time information data, an analysis of AE onset time using weibull distribution was performed to examine the AE onset time profile for each ­drug[16,17,18] This is the first report to comprehensively analyze the relationship between antibiotics and taste and smell disorders

Objectives
Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.